文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

天然产物在癌症免疫治疗中的新兴作用。

Emerging role of natural products in cancer immunotherapy.

作者信息

Dong Songtao, Guo Xiangnan, Han Fei, He Zhonggui, Wang Yongjun

机构信息

Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.

School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.

出版信息

Acta Pharm Sin B. 2022 Mar;12(3):1163-1185. doi: 10.1016/j.apsb.2021.08.020. Epub 2021 Aug 21.


DOI:10.1016/j.apsb.2021.08.020
PMID:35530162
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9069318/
Abstract

Cancer immunotherapy has become a new generation of anti-tumor treatment, but its indications still focus on several types of tumors that are sensitive to the immune system. Therefore, effective strategies that can expand its indications and enhance its efficiency become the key element for the further development of cancer immunotherapy. Natural products are reported to have this effect on cancer immunotherapy, including cancer vaccines, immune-check points inhibitors, and adoptive immune-cells therapy. And the mechanism of that is mainly attributed to the remodeling of the tumor-immunosuppressive microenvironment, which is the key factor that assists tumor to avoid the recognition and attack from immune system and cancer immunotherapy. Therefore, this review summarizes and concludes the natural products that reportedly improve cancer immunotherapy and investigates the mechanism. And we found that saponins, polysaccharides, and flavonoids are mainly three categories of natural products, which reflected significant effects combined with cancer immunotherapy through reversing the tumor-immunosuppressive microenvironment. Besides, this review also collected the studies about nano-technology used to improve the disadvantages of natural products. All of these studies showed the great potential of natural products in cancer immunotherapy.

摘要

癌症免疫疗法已成为新一代抗肿瘤治疗方法,但其适应症仍集中在对免疫系统敏感的几种肿瘤类型上。因此,能够扩大其适应症并提高其疗效的有效策略成为癌症免疫疗法进一步发展的关键因素。据报道,天然产物对癌症免疫疗法有这种作用,包括癌症疫苗、免疫检查点抑制剂和过继性免疫细胞疗法。其机制主要归因于肿瘤免疫抑制微环境的重塑,这是协助肿瘤逃避免疫系统和癌症免疫疗法识别与攻击的关键因素。因此,本综述总结并归纳了据报道可改善癌症免疫疗法的天然产物,并研究了其机制。我们发现皂苷、多糖和黄酮类化合物是主要的三类天然产物,它们通过逆转肿瘤免疫抑制微环境,在与癌症免疫疗法联合应用时显示出显著效果。此外,本综述还收集了有关用于改善天然产物缺点的纳米技术的研究。所有这些研究都表明天然产物在癌症免疫疗法中具有巨大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d33/9069318/aafbad476b3c/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d33/9069318/d1d624ced8e6/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d33/9069318/045b2f16fdd2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d33/9069318/bcd157cd4347/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d33/9069318/b01fcc94db71/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d33/9069318/fc3322eaf137/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d33/9069318/80a762a1fa01/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d33/9069318/0a5a45519d98/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d33/9069318/aae1b553c96b/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d33/9069318/17c9cb3d0eaa/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d33/9069318/b7654f2faf82/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d33/9069318/aafbad476b3c/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d33/9069318/d1d624ced8e6/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d33/9069318/045b2f16fdd2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d33/9069318/bcd157cd4347/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d33/9069318/b01fcc94db71/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d33/9069318/fc3322eaf137/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d33/9069318/80a762a1fa01/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d33/9069318/0a5a45519d98/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d33/9069318/aae1b553c96b/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d33/9069318/17c9cb3d0eaa/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d33/9069318/b7654f2faf82/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d33/9069318/aafbad476b3c/gr10.jpg

相似文献

[1]
Emerging role of natural products in cancer immunotherapy.

Acta Pharm Sin B. 2022-3

[2]
Biological drug and drug delivery-mediated immunotherapy.

Acta Pharm Sin B. 2021-4

[3]
Clinically feasible approaches to potentiating cancer cell-based immunotherapies.

Hum Vaccin Immunother. 2015

[4]
The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.

Bioact Mater. 2020-12-26

[5]
Therapeutic gene modified cell based cancer vaccines.

Gene. 2013-4-6

[6]
Application of PD-1 Blockade in Cancer Immunotherapy.

Comput Struct Biotechnol J. 2019-5-23

[7]
Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy.

Oncoimmunology. 2015-2-3

[8]
Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer.

Cancer Lett. 2013-8-17

[9]
Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice.

J Bone Oncol. 2019-3-19

[10]
Platinum-based chemotherapy in combination with PD-1/PD-L1 inhibitors: preclinical and clinical studies and mechanism of action.

Expert Opin Drug Deliv. 2021-2

引用本文的文献

[1]
AMPs inhibit the proliferation, migration, and invasion of lung cancer via the CHRM3/PI3K/AKT and CHRM3/MAPK pathways.

Front Oncol. 2025-7-11

[2]
Preoperative MRI-based radiomics analysis of intra- and peritumoral regions for predicting CD3 expression in early cervical cancer.

Sci Rep. 2025-7-23

[3]
Unveiling the role of TAM-derived extracellular vesicles in glioma progression through Treg polarization and immune suppression.

Oncogene. 2025-7-18

[4]
APOE deficiency triggers anti-tumour activity of macrophages in liver cancer.

Cancer Gene Ther. 2025-7-14

[5]
In silico identification of promising PD-L1 inhibitors from selected indian medicinal plants for treatment of triple negative breast cancer.

PLoS One. 2025-7-10

[6]
Cantharidin-Loaded Nanomedicine Modified with Amphiphilic Peptides Induce Immunogenic Cell Death to Enhance PD-1 Blockade.

ACS Appl Mater Interfaces. 2025-7-23

[7]
Recent advances in novel tumor immunotherapy strategies based on regulating the tumor microenvironment and immune checkpoints.

Front Immunol. 2025-6-18

[8]
NGR-modified nanovesicles target ALKBH5 to inhibit ovarian cancer growth and metastasis.

Theranostics. 2025-6-9

[9]
Unveiling the dual role of circulating tumor cells in colorectal cancer immunotherapy: a comprehensive review of biomarker utility and immune microenvironment crosstalk.

Front Immunol. 2025-6-6

[10]
The spatiotemporal heterogeneity of reactive oxygen species in the malignant transformation of viral hepatitis to hepatocellular carcinoma: a new insight.

Cell Mol Biol Lett. 2025-6-14

本文引用的文献

[1]
Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy.

Signal Transduct Target Ther. 2021-2-20

[2]
Overcoming hurdles in cancer immunotherapy.

Nat Rev Microbiol. 2021-4

[3]
Targeting the epigenetic regulation of antitumour immunity.

Nat Rev Drug Discov. 2020-11

[4]
Turning up the heat on non-immunoreactive tumours: opportunities for clinical development.

Lancet Oncol. 2020-9

[5]
Cancer immunotherapy comes of age and looks for maturity.

Nat Commun. 2020-7-3

[6]
MyD88-dependent and -independent signalling via TLR3 and TLR4 are differentially modulated by Δ-tetrahydrocannabinol and cannabidiol in human macrophages.

J Neuroimmunol. 2020-3-20

[7]
Effect and Molecular Mechanisms of Traditional Chinese Medicine on Tumor Targeting Tumor-Associated Macrophages.

Drug Des Devel Ther. 2020

[8]
A Potential Herbal Adjuvant Combined With a Peptide-Based Vaccine Acts Against HPV-Related Tumors Through Enhancing Effector and Memory T-Cell Immune Responses.

Front Immunol. 2020

[9]
Panaxadiol inhibits programmed cell death-ligand 1 expression and tumour proliferation via hypoxia-inducible factor (HIF)-1α and STAT3 in human colon cancer cells.

Pharmacol Res. 2020-5

[10]
Dual pH-sensitive nanodrug blocks PD-1 immune checkpoint and uses T cells to deliver NF-κB inhibitor for antitumor immunotherapy.

Sci Adv. 2020-2-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索